Article
SF3B1 mutant-induced missplicing of MAP3K7 causes anemia in myelodysplastic syndromes.
Proceedings of the National Academy of Sciences of the United States of America - 4 Jan 2022
Lieu Yen K, Liu Zhaoqi, Ali Abdullah M, Wei Xin, Penson Alex, Zhang Jian, An Xiuli, Rabadan Raul, Raza Azra, Manley James L, Mukherjee Siddhartha
Abstract excerpt
SF3B1 is the most frequently mutated RNA splicing factor in cancer, including in ∼25% of myelodysplastic syndromes (MDS) patients. SF3B1-mutated MDS, which is strongly associated with ringed sideroblast morphology, is characterized by ineffective erythropoiesis, leading to severe, often fatal anemia. However, functional evidence linking SF3B1 mutations to the anemia described in MDS patients harboring this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
